GlassScriptPhysician profile
Jeffrey Nelson James
NPI 1225202484
$5,746.75
in general payments reported to CMS, 2019-2025
12 companies · $1,940 in 2025
The $1,940 reported for 2025 was more than what 92% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $503 · 2021: $322 · 2022: $337 · 2023: $1,008 · 2024: $1,391 · 2025: $1,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,312 · Gift: $27.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,311.78 |
| Gift | $27.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,962.26 | 2020-2025 | Matrixmandible, Matrixcombo, Trumatch |
| Kls-Martin L.P. | $1,269.40 | 2019-2025 | |
| Straumann USA LLC | $833.36 | 2021-2025 | |
| Zimvie INC. | $703.86 | 2023-2025 | |
| Stryker Corporation | $283.27 | 2019-2025 | Na, Smartlock, Vsp System, Vsp Cranial |
| Zimmer Biomet Holdings, INC. | $179.95 | 2019-2024 | |
| Lifenet Health | $144.25 | 2022 | |
| Alafair Biosciences, INC. | $120.08 | 2025 | Versawrap |
| Biohorizons Implant Systems INC. | $76.17 | 2022-2024 | Biohorizons |
| Axogen | $71.37 | 2019-2025 | |
| Kerecis Limited | $67.05 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Nobel Biocare USA | $35.73 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.